D.E. Shaw & Co’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,346,898
| Closed | -$56.8M | – | 4603 |
|
|
2023
Q2 | $56.8M | Sell |
1,346,898
-1,932,876
| -59% | -$78.2M | 0.06% | 390 |
|
|
2023
Q1 | $117M | Buy |
3,279,774
+1,317,919
| +67% | +$47.8M | 0.13% | 179 |
|
|
2022
Q4 | $72M | Buy |
1,961,855
+1,823,391
| +1,317% | +$72.1M | 0.08% | 283 |
|
|
2022
Q3 | $6.53M | Buy |
138,464
+128,740
| +1,324% | +$8.32M | 0.01% | 1786 |
|
|
2022
Q2 | $697K | Buy |
+9,724
| New | +$711K | ﹤0.01% | 3862 |
|
|
2021
Q2 | – | Sell |
-3,359
| Closed | -$255K | – | 5105 |
|
|
2021
Q1 | $255K | Sell |
3,359
-88,897
| -96% | -$6.7M | ﹤0.01% | 3770 |
|
|
2020
Q4 | $6.29M | Sell |
92,256
-241,904
| -72% | -$15.1M | 0.01% | 1692 |
|
|
2020
Q3 | $17.8M | Buy |
334,160
+164,135
| +97% | +$9.77M | 0.02% | 896 |
|
|
2020
Q2 | $9.9M | Sell |
170,025
-71,556
| -30% | -$3.85M | 0.01% | 1198 |
|
|
2020
Q1 | $9.52M | Sell |
241,581
-9,162
| -4% | -$536K | 0.01% | 1021 |
|
|
2019
Q4 | $14.9M | Buy |
250,743
+144,400
| +136% | +$7.76M | 0.02% | 971 |
|
|
2019
Q3 | $5.66M | Buy |
106,343
+13,490
| +15% | +$692K | 0.01% | 1558 |
|
|
2019
Q2 | $4.74M | Sell |
92,853
-101,424
| -52% | -$4.72M | 0.01% | 1625 |
|
|
2019
Q1 | $10.1M | Sell |
194,277
-337,714
| -63% | -$16.4M | 0.01% | 1097 |
|
|
2018
Q4 | $20.9M | Buy |
531,991
+120,829
| +29% | +$5.61M | 0.03% | 696 |
|
|
2018
Q3 | $21.2M | Buy |
411,162
+246,452
| +150% | +$12.1M | 0.03% | 752 |
|
|
2018
Q2 | $7.72M | Sell |
164,710
-127,435
| -44% | -$5.27M | 0.01% | 1242 |
|
|
2018
Q1 | $10.4M | Sell |
292,145
-349,508
| -54% | -$13.7M | 0.01% | 974 |
|
|
2017
Q4 | $28M | Sell |
641,653
-485,770
| -43% | -$22.7M | 0.04% | 535 |
|
|
2017
Q3 | $59M | Sell |
1,127,423
-337,896
| -23% | -$18.8M | 0.09% | 270 |
|
|
2017
Q2 | $85.7M | Buy |
1,465,319
+1,047,882
| +251% | +$54.5M | 0.14% | 168 |
|
|
2017
Q1 | $19.1M | Buy |
417,437
+17,034
| +4% | +$847K | 0.03% | 597 |
|
|
2016
Q4 | $21.1M | Buy |
400,403
+32,545
| +9% | +$1.58M | 0.04% | 604 |
|
|
2016
Q3 | $16.4M | Sell |
367,858
-116,547
| -24% | -$5.06M | 0.03% | 660 |
|
|
2016
Q2 | $18.5M | Buy |
484,405
+122,736
| +34% | +$5.39M | 0.03% | 583 |
|
|
2016
Q1 | $14.9M | Buy |
361,669
+22,093
| +7% | +$911K | 0.03% | 658 |
|
|
2015
Q4 | $16.5M | Buy |
339,576
+104,137
| +44% | +$4.63M | 0.02% | 729 |
|
|
2015
Q3 | $9.42M | Buy |
235,439
+144,633
| +159% | +$6.32M | 0.01% | 998 |
|
|
2015
Q2 | $3.64M | Buy |
90,806
+48,110
| +113% | +$1.66M | 0.01% | 1722 |
|
|
2015
Q1 | $1.4M | Buy |
42,696
+16,696
| +64% | +$461K | ﹤0.01% | 2289 |
|
|
2014
Q4 | $668K | Buy |
+26,000
| New | +$618K | ﹤0.01% | 3121 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
D.E. Shaw & Co's SYNH Position: Q3 2023 in Review
D.E. Shaw & Co sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,346,898 shares — an estimated $56.8M sold.
D.E. Shaw & Co first reported a position in SYNH in Q4 2014 and held it in 31 quarters. The position peaked at $117M in Q1 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- D.E. Shaw & Co reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- D.E. Shaw & Co sold 1,346,898 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $56.8M.
- D.E. Shaw & Co first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 31 quarters.
- D.E. Shaw & Co's Syneos Health, Inc. Class A Common Stock position peaked at $117M in Q1 2023.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.